Effective presence of antibodies against common human coronaviruses in immunoglobulin medicinal products

Effective presence of antibodies against common human coronaviruses in immunoglobulin medicinal products

ABSTRACT: Background: Immunoglobulin products (for intravenous, intramuscular and subcutaneous administration) prepared from geographically diverse plasma pools were tested for activity against common human coronaviruses (HCoVs). Products from plasma obtained from Germany, Czech Republic, Slovak Re...

Full description

Bibliographic Details
Main Authors:	José María Díez, Carolina Romero, Rodrigo Gajardo
Format:	Article
Language:	English
Published:	Elsevier 2022-03-01
Series:	International Journal of Infectious Diseases
Subjects:	Human coronavirus Antibodies Immunoglobulins
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971221012285

Similar Items

Seroprevalence of Severe Acute Respiratory Syndrome-Coronavirus-2 Immunoglobulin M and Immunoglobulin G Antibodies among the Population of Koya University
by: Safia S. I. Blbas, et al.
Published: (2021-11-01)

Functionality of Immunoglobulin G and Immunoglobulin M Antibody Physisorbed on Cellulosic Films
by: Ziwei Huang, et al.
Published: (2017-07-01)

Comparison of indigenous enzyme-linked immunosorbent assay and chemiluminescent immunoassays for screening for immunoglobulin G antibodies against SARS-CoV-2 in India
by: Nitu Chauhan, et al.
Published: (2021-01-01)

Fundamental differences between natural antibodies and polyreactive immunoglobulins
by: S. A. Bobrovnik, et al.
Published: (2015-10-01)

Injection of intravenous immunoglobulin (IVIg) for the treatment of Coronavirus induced cytokine storm
by: Farahnoosh Farnood, et al.
Published: (2022-12-01)

Characterization of antibodies in human immunoglobulin products from different regions worldwide
by: Alexandra Serra, et al.
Published: (2021-03-01)

Severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibody: Seroprevalence among contacts of COVID-19 cases
by: Om Prakash, et al.
Published: (2021-01-01)

Immunoglobulin: production, mechanisms of action and formulations
by: Marcia Cristina Zago Novaretti, et al.
Published: (2011-10-01)

Aptamers against Immunoglobulins: Design, Selection and Bioanalytical Applications
by: Zsófia Bognár, et al.
Published: (2020-08-01)

Preparation and purification of anti immunoglobulin Y antibodies from rabbit
by: M Pour Amir, et al.
Published: (2004-01-01)

Function matters: Coronavirus cross-binding antibodies do not cross-neutralize
by: Maria R. Farcet, et al.
Published: (2022-08-01)

The Influence of Pre-Existing Immunity against Human Common Cold Coronaviruses on COVID-19 Susceptibility and Severity
by: Erick De La Torre Tarazona, et al.
Published: (2023-09-01)

Evaluation of Serum Antibody Levels and Presence of Neutralizing Antibodies in Patients with Mild and Moderate Coronavirus Disease-2019
by: Esra ÖZKAYA, et al.
Published: (2022-08-01)

Assessment of immunoglobulin G antibodies against oxidized low-density lipoproteins in patients with acute coronary syndrome
by: Mohamed S Mokhtar, et al.
Published: (2013-01-01)

Production and characterization of polyclonal antibody against Bengal tiger (Panthera tigris tigris) immunoglobulin G
by: Chanakan Areewong, et al.
Published: (2019-01-01)

Cross-Reactivity of Antibodies in Intravenous Immunoglobulin Preparation for Protection against SARS-CoV-2
by: Toshifumi Osaka, et al.
Published: (2023-02-01)

Omalizumab: an anti-immunoglobulin E antibody for the treatment of allergic respiratory diseases
by: J. Bousquet, et al.
Published: (2008-04-01)

Treatment of a case of COVID-19 by intravenous immunoglobulin
by: Mustafa Çolak, et al.
Published: (2021-03-01)

Potential therapeutic approach of intravenous immunoglobulin against COVID-19
by: Zahra Kolahchi, et al.
Published: (2021-10-01)

Fish Immunoglobulins
by: Sara Mashoof, et al.
Published: (2016-11-01)

Trough Concentrations of Specific Antibodies in Primary Immunodeficiency Patients Receiving Intravenous Immunoglobulin Replacement Therapy
by: Ori Hassin, et al.
Published: (2021-02-01)

INTRAVENOUS IMMUNOGLOBULIN ADMINISTRATION FOR DESENSITIZATION BEFORE RENAL TRANSPLANTATION AND MANAGING ANTIBODY-MEDIATED REJECTION
by: A. I. Sushkov, et al.
Published: (2011-06-01)

Immunoglobulins or Antibodies: IMGT<sup>®</sup> Bridging Genes, Structures and Functions
by: Marie-Paule Lefranc, et al.
Published: (2020-08-01)

USE OF INTRAVENOUS IMMUNOGLOBULIN WITHIN THE IVF/ICSI PROTOCOL IN WOMEN WITH INFERTILITY AND ANTIPHOSPHOLIPID ANTIBODIES
by: M. I. Krivonos, et al.
Published: (2017-12-01)

The structures of secretory and dimeric immunoglobulin A
by: Sonya Kumar Bharathkar, et al.
Published: (2020-10-01)

Methods to Measure Antibody Neutralization of Live Human Coronavirus OC43
by: Jim Boonyaratanakornkit, et al.
Published: (2021-10-01)

Immunoglobulin replacement therapies in inborn errors of immunity: a review
by: Archan Sil, et al.
Published: (2024-02-01)

Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection
by: Steven Rockman, et al.
Published: (2017-05-01)

ELISA-based assay of immunoglobulin G antibodies against mammalian cell entry 1A (Mce1A) protein: a novel diagnostic approach for leprosy
by: Filipe R Lima, et al.

Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
by: Philipp Scheuerlein, et al.
Published: (2018-07-01)

Treatment of donor‐specific antibody‐mediated rejection after heart transplantation by IgM‐enriched human immunoglobulin
by: Moritz Benjamin Immohr, et al.
Published: (2021-08-01)

Reprogramming the Constant Region of Immunoglobulin G Subclasses for Enhanced Therapeutic Potency against Cancer
by: Tae Hyun Kang, et al.
Published: (2020-03-01)

Fatigue Is Common in Immunoglobulin G Subclass Deficiency and Correlates With Inflammatory Response and Need for Immunoglobulin Replacement Therapy
by: Per Wågström, et al.
Published: (2022-01-01)

Multiple Myeloma Baseline Immunoglobulin G Level and Pneumococcal Vaccination Antibody Response
by: Michael A. Thompson, et al.
Published: (2017-08-01)

Passive Transfer of Hepatitis B Antibodies through Intravenous Immunoglobulin in a Neonate
by: João Rato, et al.
Published: (2019-12-01)

Ten-year population trends of immunoglobulin use, burden of adult antibody deficiency and feasibility of subcutaneous immunoglobulin (SCIg) replacement in Hong Kong Chinese
by: Andy Ka Chun Kan, et al.
Published: (2022-12-01)

Effect of trifluoroethanol on antibody reactivity against corresponding and nonrelated antigens
by: S. A. Bobrovnik, et al.
Published: (2018-07-01)

Antibodies and vaccines against Middle East respiratory syndrome coronavirus
by: Jiuyang Xu, et al.
Published: (2019-01-01)

Determination of antibodies in everyday rheumatological practice
by: Katarzyna Napiórkowska-Baran, et al.
Published: (2019-04-01)

Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?
by: Michael Asamoah-Boaheng, et al.
Published: (2022-09-01)